The American Journal of Psychiatry
Journal Home Search Current Issue Past Issues Subscribe All APPI Journals Help Contact Us
 
Quicksearch
Advanced Search
Or Search All APPI Journals
This Article
* Full Text (PDF)
* Alert me when this article is cited
* Alert me if a correction is posted
* Citation Map
Services
* Email this article to a Colleague
* Similar articles in this journal
* Similar articles in PubMed
* Alert me to new issues of the journal
* Add to My Articles & Searches
* Download to citation manager
* reprints & permissions
Citing Articles
* Citing Articles via HighWire
* Citing Articles via Google Scholar
Google Scholar
* Articles by Mavissakalian, M.
* Articles by Michelson, L.
* Search for Related Content
PubMed
* PubMed Citation
* Articles by Mavissakalian, M.
* Articles by Michelson, L.

Am J Psychiatry 1986; 143:1106-1112
Copyright © 1986 by American Psychiatric Association


REGULAR ARTICLES

Two-year follow-up of exposure and imipramine treatment of agoraphobia

M Mavissakalian and L Michelson

Sixty-two agoraphobic patient who had completed a controlled study of therapist-assisted in vivo exposure (flooding) and imipramine were assessed 1 month, 6 months, 1 year, and 2 years later. Overall, improvement during treatment was maintained throughout follow-up. At 1 month but not subsequently, imipramine and flooding had significant effects on central measures of agoraphobia. Patients who were marked treatment responders had a favorable clinical course and did not experience secondary depression, unlike patients who had not responded markedly to treatment. These findings suggest that treatments which evoke maximum therapeutic benefit initially are likely to foster long- term maintenance and reduce subsequent depressive sequelae.


This article has been cited by other articles:


Home page
FocusHome page
B. Milrod, A. C. Leon, F. Busch, M. Rudden, M. Schwalberg, J. Clarkin, A. Aronson, M. Singer, W. Turchin, E. T. Klass, et al.
A Randomized Controlled Clinical Trial of Psychoanalytic Psychotherapy for Panic Disorder
Focus, October 1, 2008; 6(4): 496 - 504.
[Abstract] [Full Text] [PDF]


Home page
Am. J. PsychiatryHome page
B. Milrod, A. C. Leon, F. Busch, M. Rudden, M. Schwalberg, J. Clarkin, A. Aronson, M. Singer, W. Turchin, E. T. Klass, et al.
A Randomized Controlled Clinical Trial of Psychoanalytic Psychotherapy for Panic Disorder
Am J Psychiatry, February 1, 2007; 164(2): 265 - 272.
[Abstract] [Full Text] [PDF]


Home page
J. Psychother. Pract. Res.Home page
B. Milrod, F. Busch, A. C. Leon, A. Aronson, J. Roiphe, M. Rudden, M. Singer, T. Shapiro, H. Goldman, D. Richter, et al.
A Pilot Open Trial of Brief Psychodynamic Psychotherapy for Panic Disorder
J Psychother Pract Res., October 1, 2001; 10(4): 239 - 245.
[Abstract] [Full Text]


Home page
J PsychopharmacolHome page
F. Lotufo-Neto, M. Bernik, R. T. Ramos, L. Andrade, C. Gorenstein, T. Cordas, M. Melo, and V. Gentil
A dose-finding and discontinuation study of clomipramine in panic disorder
J Psychopharmacol, January 1, 2001; 15(1): 13 - 17.
[Abstract] [PDF]


Home page
JAMAHome page
D. H. Barlow, J. M. Gorman, M. K. Shear, and S. W. Woods
Cognitive-Behavioral Therapy, Imipramine, or Their Combination for Panic Disorder: A Randomized Controlled Trial
JAMA, May 17, 2000; 283(19): 2529 - 2536.
[Abstract] [Full Text] [PDF]


Home page
Am. J. PsychiatryHome page
J. M. Gorman, M. K. Shear, J. S. McIntyre, and D. A. Zarin
Drs. Gorman, Shear, McIntyre, and Zarin Reply
Am J Psychiatry, December 1, 1998; 155(12): 1799 - 1800.
[Full Text]


Home page
Arch Fam MedHome page
L. S. Meredith, C. D. Sherbourne, C. A. Jackson, P. Camp, and K. B. Wells
Treatment Typically Provided for Comorbid Anxiety Disorders
Arch Fam Med, May 1, 1997; 6(3): 231 - 237.
[Abstract] [PDF]


Home page
Behav ModifHome page
R. Van Dyck and P. Spinhoven
Does Preference for Iype of Treatment Matter?: A Study of Exposure In Vivo with or without Hypnosis in the Treatment of Panic Disorder with Agoraphobia
Behav Modif, April 1, 1997; 21(2): 172 - 186.
[Abstract] [PDF]


Home page
Arch Gen PsychiatryHome page
E. Schweizer, K. Rickels, S. Weiss, and S. Zavodnick
Maintenance Drug Treatment of Panic Disorder: I. Results of a Prospective, Placebo-Controlled Comparison of Alprazolam and Imipramine
Arch Gen Psychiatry, January 1, 1993; 50(1): 51 - 60.
[Abstract] [PDF]


Home page
Arch Gen PsychiatryHome page
K. Rickels, E. Schweizer, S. Weiss, and S. Zavodnick
Maintenance Drug Treatment for Panic Disorder: II. Short- and Long-term Outcome After Drug Taper
Arch Gen Psychiatry, January 1, 1993; 50(1): 61 - 68.
[Abstract] [PDF]


Home page
J PsychopharmacolHome page
H.C. Middleton
Psychology and pharmacology in the treatment of anxiety disorders: co-operation or confrontation
J Psychopharmacol, January 1, 1991; 5(4): 281 - 285.
[Abstract] [PDF]


Home page
J PsychopharmacolHome page
H.C. Middleton
'Psychological inflammation'. Clarification of the model and a rejoinder
J Psychopharmacol, January 1, 1991; 5(4): 301 - 304.
[PDF]


Home page
Arch Gen PsychiatryHome page
R. Noyes Jr, J. Reich, J. Christiansen, M. Suelzer, B. Pfohl, and W. A. Coryell
Outcome of Panic Disorder: Relationship to Diagnostic Subtypes and Comorbidity
Arch Gen Psychiatry, September 1, 1990; 47(9): 809 - 818.
[Abstract] [PDF]


Home page
Arch Gen PsychiatryHome page
J. S. Markowitz, M. M. Weissman, R. Ouellette, J. D. Lish, and G. L. Klerman
Quality of Life in Panic Disorder
Arch Gen Psychiatry, November 1, 1989; 46(11): 984 - 992.
[Abstract] [PDF]


Home page
Arch Gen PsychiatryHome page
L. M. Nagy, J. H. Krystal, S. W. Woods, and D. S. Charney
Clinical and Medication Outcome After Short-term Alprazolam and Behavorial Group Treatment in Panic Disorder: 2.5-Year Naturalistic Follow-up Study
Arch Gen Psychiatry, November 1, 1989; 46(11): 993 - 999.
[Abstract] [PDF]


Home page
Arch Gen PsychiatryHome page
J. C. Ballenger, G. D. Burrows, R. L. DuPont Jr, I. M. Lesser, R. Noyes Jr, J. C. Pecknold, A. Rifkin, and R. P. Swinson
Alprazolam in Panic Disorder and Agoraphobia: Results From a Multicenter Trial: I. Efficacy in Short-term Treatment
Arch Gen Psychiatry, May 1, 1988; 45(5): 413 - 422.
[Abstract] [PDF]


Home page
Arch Gen PsychiatryHome page
I. M. Lesser, R. T. Rubin, J. C. Pecknold, A. Rifkin, R. P. Swinson, R. B. Lydiard, G. D. Burrows, R. Noyes Jr, and R. L. DuPont Jr
Secondary Depression in Panic Disorder and Agoraphobia: I. Frequency, Severity, and Response to Treatment
Arch Gen Psychiatry, May 1, 1988; 45(5): 437 - 443.
[Abstract] [PDF]




Get information about faster international access.

Privacy Policy

Copyright © 1986 American Psychiatric Association. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us

American Psychiatric Publishing, Inc. American Psychiatric Association
1000 Wilson Boulevard, Suite 1825, Arlington, VA 22209-3901 * 800-368-5777 * appi at psych.org